These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 630909)

  • 1. Metabolic effects and anti-obesity action of fenfluramine in prolonged-acting form.
    Ranquin R; Brems HM
    Curr Med Res Opin; 1977-1978; 5(4):341-6. PubMed ID: 630909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged-action fenfluramine in non-diabetic patients with refractory obesity.
    Galloway DB; Logie AW; Petrie JC
    Postgrad Med J; 1975; 51 Suppl 1():155-7. PubMed ID: 768957
    [No Abstract]   [Full Text] [Related]  

  • 3. The metabolic effects, and the composition of the tissue lost, in weight reduction by obese patients on treatment with fenfluramine.
    Durnin JV; Womersley J
    Br J Pharmacol; 1973 Sep; 49(1):115-20. PubMed ID: 4595485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical observations on the treatment of obese patients with dexfenfluramine].
    Cairella M; Pisculli M; Petraroli AR; Riganelli S; Saracino A; Siani V
    Clin Ter; 1990 Jun; 133(5):289-97. PubMed ID: 2143712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of a low-calorie diet with and without fenfluramine, and fenfluramine alone on the glucose tolerance and insulin secretion of overweight non-diabetics.
    Dykes JR
    Postgrad Med J; 1973 May; 49(571):314-7. PubMed ID: 4804455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of fenfluramine in hypertriglyceridemic obese subjects.
    Brun LD; Bielmann P; Gagne C; Moorjani S; Nadeau A; Lupien PJ
    Int J Obes; 1988; 12(5):423-31. PubMed ID: 3069765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexfenfluramine treatment of obesity: a double blind trial with post trial follow up.
    O'Connor HT; Richman RM; Steinbeck KS; Caterson ID
    Int J Obes Relat Metab Disord; 1995 Mar; 19(3):181-9. PubMed ID: 7780494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical trial of a new long-acting fenfluramine in the treatment of obesity].
    Pugnoli C; Bandini L; Caronna S; Ciarlini E; Magnati G; Strata A; Tirelli F
    G Clin Med; 1978 Nov; 59(11):486-510. PubMed ID: 369930
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of hypocaloric diet with and without D-fenfluramine treatment on growth hormone release after growth hormone-releasing factor stimulation in patients with android obesity.
    Medeiros-Neto G; Lima N; Perozim L; Pedrinola F; Wajchenberg BL
    Metabolism; 1994 Aug; 43(8):969-73. PubMed ID: 8052154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment with fenfluramine in obese subjects.
    Sensi S; Della Loggia F; Del Ponte A; Guagnano MT
    Int J Clin Pharmacol Res; 1985; 5(4):247-53. PubMed ID: 4055167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended-release fenfluramine: patient acceptance and efficacy of evening dosing.
    Weintraub M; Sriwatanakul K; Sundaresan PR; Weis OF; Dorn M
    Clin Pharmacol Ther; 1983 May; 33(5):621-7. PubMed ID: 6340909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A controlled investigation of the "glycolyptic" action of fenfluramine.
    Garrow JS; Belton EA; Daniels A
    Lancet; 1972 Sep; 2(7777):559-61. PubMed ID: 4115737
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of a long acting preparation of fenfluramine on body weight, body composition and skinfold thickness in obese subjects.
    Balasse EO; Couturier E; Kornitzer M; Degre S
    Postgrad Med J; 1975; 51 Suppl 1():157. PubMed ID: 768958
    [No Abstract]   [Full Text] [Related]  

  • 14. Prolonged action fenfluramine in general practice.
    Owen JH
    Br J Clin Pract; 1975 Jan; 29(1):13-14. PubMed ID: 1095043
    [No Abstract]   [Full Text] [Related]  

  • 15. [Influence of fenfluramine on the weekly curve of weight loss during obesity].
    Cabezas Cerrato J; Gómez Pérez M; Marco-Mur AL; Camarero E; Fernández-Cruz A
    Rev Clin Esp; 1974 Jan; 132(1):47-52. PubMed ID: 4840227
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and safety of dexfenfluramine in obese patients: a multicenter study.
    Enzi G; Crepaldi G; Inelmen EM; Bruni R; Baggio B
    Clin Neuropharmacol; 1988; 11 Suppl 1():S173-8. PubMed ID: 3052815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind clinical trial in weight control. Use of fenfluramine and phentermine alone and in combination.
    Weintraub M; Hasday JD; Mushlin AI; Lockwood DH
    Arch Intern Med; 1984 Jun; 144(6):1143-8. PubMed ID: 6375610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged action fenfluramine capsules versus fenfluramine tablets in general practice.
    Maneksha S
    Br J Clin Pract; 1975 Jan; 29(1):12-13. PubMed ID: 1095042
    [No Abstract]   [Full Text] [Related]  

  • 19. Acceptability of prolonged release fenfluramine capsules in obese patients in general practice.
    Owen JH
    Postgrad Med J; 1975; 51 Suppl 1():176-7. PubMed ID: 768964
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of 6 months therapy with dexfenfluramine in obese patients: studies in the United Kingdom.
    Finer N; Craddock D; Lavielle R; Keen H
    Clin Neuropharmacol; 1988; 11 Suppl 1():S179-86. PubMed ID: 3052816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.